Displaying items by tag: women
We’re looking for adults with ASCVD or high risk for ASCVD to join the V-INCLUSION Study, evaluating a new FDA-approved cholesterol-lowering injection called Inclisiran.
You may qualify if you:
✔️ Have a history of heart attack, stroke, TIA, or peripheral artery disease
✔️ Are currently taking a statin or have statin intolerance
✔️ Have high LDL-C (bad cholesterol)
✔️ Identify as female, live in a rural area, or are from an underrepresented racial or ethnic group
What’s in it for you?
✅ Free access to Inclisiran for at least one year
✅ Compensation provided for participation
✅ Extra monitoring and heart health screening in addition to your usual care
✅ Advance research that may improve heart health in underserved communities
? Half of participants will receive Inclisiran during Year 1, the other half in Year 2.
? Your participation may help shape better cardiovascular care for future generations.
?Spots are limited. Contact us today to see if you’re eligible!
Contact us at: 205-934-5217
Who's eligible for the study?
If you have been diagnosed with depression.
If you are between the ages of 18-64
If you are currently experiencing a major depressive episode that has lasted at least 3 weeks but not longer than 18 months.
If you are otherwise healthy and have not been diagnosed with other medically important conditions or psychiatric conditions such as bipolar disorder (BP), antisocial personality disorder (ASPD), obsessive compulsive disorder (OCD), borderline personality disorder (BPD) or attention-deficit/hyperactivity disorder (ADHD) or major diseases, have not had electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), deep brain stimulation or repetitive transcranial magnetic stimulation (TMS) within 5 years or have failed to respond to ECT at any time, This STUDY Might Be For You!
For more information, contact Dana Green at danagreen@uabmc.edu or 205-975-6426.
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples.
Participants will be compensated $675 for completing all the visits.
To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
The purpose of this NIH-funded trial is to examine the effects of three different diabetes treatments to determine if they improve night-time blood sugars.
This trial involves:
- A screening visit that includes a blood draw, urine test and physical exam
- Treatment with Metformin, Insulin Glargine (long-acting insulin) or the experimental drug Dorzagliatin which is FDA-approved for research, for up to 8 weeks
- 2-4 inpatient visits/ including two overnight stays at the Clinical Research Unit at 15th floor of Jefferson Tower.
- All visits to be completed within a three-month period.
Study-related tests and procedures are provided free of charge. Participants will be compensated up to $2,500 for study completion. All participants must be diagnosed with type 2 DM and not be on any type of insulin therapy.
Please contact Alaaeldin Hodhod at ahodhod@uabmc.edu or 205-996-9984 or Chanel Mason at 205-934-1921 or cnmason@uabmc.edu.
The UAB Office of Psychiatric Research is actively recruiting participants for our studies and wants to connect with you on our research! Whether you are needing someone to talk to, or even have no history of mental health conditions and are just wanting to further knowledge within the medical and mental health field, we would love to get you involved!
Our studies can be broken down into two different categories:
1) TREATMENT STUDIES – Our Treatment Studies are designed to evaluate the effectiveness of new antidepressants on individuals living with Major Depressive Disorder or Treatment-Resistant Depression.
2) NON-TREATMENT STUDIES – Our Non-Treatment Studies do NOT involve testing a new medication or intervention. Instead, these studies focus on understanding behaviors and experiences of mental health conditions via interviews, tests, or surveys.
COMPENSATION IS PROVIDED!
For more information, please reach out to the UAB Office of Psychiatric Research at (205) 934-2484 or go to: https://tinyurl.com/UABpsychiatricresearch and our team will be in contact with you shortly!
Interested in being part of vision rehabilitation research for healthy older adults aged 50-59 to lay the foundation of using a new device?
Here is an overview of what our study will involve!
The purpose of this study?
- Calculate baseline data for Bioness Integrated Therapy System (BITS) and identify its clinical implications in treating visual impairments.
- Compare the baseline data of Bioness Integrated Therapy System (BITS) to Dynavision for visual scanning.
Who are we looking for?
- Healthy adults aged 50-59 without physical, visual, or cognitive impairment and with no history of seizures or balance problems.
- Adults who are able to walk without assistive devices and are English speakers.
What would you have to do in 60 minutes?
- Fill out a short survey for demographic data.
- Quick functional screening of upper extremities.
- Perform four tests on BITS.
- Perform four tests on Dynavision.
Participants will receive a $25 gift card.
To participate in the study, please fill out this short survey:
https://uab.co1.qualtrics.com/jfe/form/SV_exEYGMKXxc230p0
For more information, please contact us at almulhim@uab.edu
If you are interested in seeing if you may qualify for an ongoing clinical study, please contact Christina Ndolo at cmndolo@uabmc.edu.
About the Clinical Trial:
The purpose of this NIH funded trial is to examine the effects of three different diabetes treatments to determine if they improve night-time blood sugars.
This Trial Involves:
- A screening visit that includes a blood draw, urine test and physical exam
- Treatment with Metformin, Insulin Glargine (long-acting insulin) or the experimental drug Dorzagliatin which is FDA-approved for research, for up to 8 weeks
- 2-4 inpatient visits/ including two overnight stays at the Clinical Research Unit at 15th floor of Jefferson Tower.
All visits to be completed within a three-month period. Study-related tests and procedures are provided free of charge. Participants will be compensated up to $2,500 for study completion. All Participants must be Diagnosed with type 2 DM and Not on any type of insulin therapy.
Please contact Chanel Mason at 205-934-1921 or cnmason@uabmc.edu, or Alaaeldin Hodhod at ahodhod@uabmc.edu.
If you experience urine leakage and you are 65 years or older, you may qualify for the study.
We are assessing whether hip exercises can improve pelvic floor muscle strength and urinary leakage.
You will serve as a “control.” At the visit, you will undergo a routine examination (10 minutes) for urinary leakage and answer questionnaires (10-15 minutes).
You will come to clinic for two visits.
$100 ($50 at each visit) compensation will be provided.
For more information, please call 205.934.5498.
- Are you 18-60 years of age living with HIV, and want to be a part of a vaccine study?
- Is your viral load suppressed/undetectable?
- Are you able to receive a vaccine?
- Are you generally healthy?
- Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a study looking at testing an experimental HIV vaccine with an experimental adjuvant to see how the immune responses change among participants who do an antiretroviral analytical treatment interruption (ATI) compared to those who do not. Compensation at each study visit will be provided for time and travel. Transportation services are also available upon request. If interested, please email sspaulding@uabmc.edu.
Participants will be compensated a total of $200. Only requires 2 visits.
For information, call us at 205-934-5498 or email: urogynecology@uabmc.edu
• A woman on parole, probation, or recently released from prison or jail?
• A woman who has used drugs?
• Interested in learning about a way to protect yourself against HIV?
You may qualify for a paid research study at the University of Alabama at Birmingham, in partnership with Yale University.
• Participate in confidential study interviews at our research office.
• Earn $50 for each interview, up to $225 for participating in the study.
Fill out our contact survey at: https://yalesurvey.ca1.qualtrics.com/jfe/form/SV_d7sAjr6GDsjiJng?Q_CHL=qr
Or you may call: (205) 934-2851 or Email: AthenaStudy@uabmc.edu
If you are interested in participating in this research and want to know more about the study, kindly follow this link to fill out our recruitment survey.